Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Gold nanoparticles with surface enhanced Raman scattering capability for the detection and treatment of glioblastoma tumours.
EF 2014-15
Résumé
There are currently over 55,000 Canadians who are surviving with a brain tumour, and an estimated 2,900 will be newly diagnosed by the end of 2014. Glioblastoma multiforme (GBM) is the most common and lethal form of these primary brain tumours, with an average patient survival time of as little as 12-15 months, even after aggressive treatment. Canadian guidelines recommend surgical removal of these brain tumours as the #1 approach for symptom improvements and prolonged survival. However, because GBM tumours can form in microscopic regions of the brain, there is high potential for tumour cells to be left behind, leading to a recurrence of the cancer in about 80-90% of cases. Additionally, the barrier between the blood and brain tissue (blood brain barrier-BBB) prevents drugs from getting access to tumour cells, and requires the usage of very high and often toxic doses. Better strategies are needed to visualize brain tumours that can guide neurosurgeons, as well as methods to overcome the BBB for drug delivery and treatment development.
Gold nanoparticles (GNPs) are spherical structures made up of gold atoms, often smaller than most viruses. GNPs can be designed with specific molecules that can be detected with imaging technology called Raman spectroscopy. We will direct these GNPs towards GBM cells in mice, after which Raman imaging can be used to distinguish the shape and outline of tumours especially in microscopic regions of the brain. We will also design GNPs with anti-cancer targets attached onto their surface as and then employ a method called focused ultrasound to temporarily open up the BBB. This method forms a pathway in the BBB through which GNPs can enter and hone in towards tumour targets in the brain, with minimal damage to normal tissue. Overall, these studies using GNPs will show promise for implementation in the operating room, and highlights the potential to progress towards non-invasive strategies in the management and treatment of brain tumours.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
318258
Name
Figueiredo Carlyn A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Gold nanoparticles with surface enhanced Raman scattering capability for the detection and treatment of glioblastoma tumours.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Brain Tumours; Focused Ultrasound; Glioblastoma; Gold Nanoparticles; Nanoneurosurgery; Nanotechnology; Non-Invasive Therapy
Abstract
There are currently over 55,000 Canadians who are surviving with a brain tumour, and an estimated 2,900 will be newly diagnosed by the end of 2014. Glioblastoma multiforme (GBM) is the most common and lethal form of these primary brain tumours, with an average patient survival time of as little as 12-15 months, even after aggressive treatment. Canadian guidelines recommend surgical removal of these brain tumours as the #1 approach for symptom improvements and prolonged survival. However, because GBM tumours can form in microscopic regions of the brain, there is high potential for tumour cells to be left behind, leading to a recurrence of the cancer in about 80-90% of cases. Additionally, the barrier between the blood and brain tissue (blood brain barrier-BBB) prevents drugs from getting access to tumour cells, and requires the usage of very high and often toxic doses. Better strategies are needed to visualize brain tumours that can guide neurosurgeons, as well as methods to overcome the BBB for drug delivery and treatment development.
Gold nanoparticles (GNPs) are spherical structures made up of gold atoms, often smaller than most viruses. GNPs can be designed with specific molecules that can be detected with imaging technology called Raman spectroscopy. We will direct these GNPs towards GBM cells in mice, after which Raman imaging can be used to distinguish the shape and outline of tumours especially in microscopic regions of the brain. We will also design GNPs with anti-cancer targets attached onto their surface as and then employ a method called focused ultrasound to temporarily open up the BBB. This method forms a pathway in the BBB through which GNPs can enter and hone in towards tumour targets in the brain, with minimal damage to normal tissue. Overall, these studies using GNPs will show promise for implementation in the operating room, and highlights the potential to progress towards non-invasive strategies in the management and treatment of brain tumours.
Competitiondate
201411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Figueiredo, Carlyn A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~